Transaction · 0000200406-26-000175

Taubert Jennifer L

Taubert Jennifer L, EVP, WIM, reported a transaction classified as exercise at JOHNSON & JOHNSON involving 15000.000000 shares for an estimated $1735050.00. Reported holdings after the transaction were 209451.001000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, WIM
JNJJOHNSON & JOHNSON
Filing timeAug 18
Trade dateAug 17, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$271.11
Pre-filing
1mo ago -6.7%1w ago -3.4%1d ago -4.0%
Returns since
7d +0.7%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

JNJ price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
JNJ since 2026-08-18Filed 17 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0000200406-26-000175
Common Stock
Transaction date
Aug 17, 2026
Filed Aug 18, 2026, 10:31 PM · 1d delay
Shares
15.0k sh
$11.5k per share
Estimated value
$173M
Computed from shares × price
Holdings after
209k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, WWC. Innovative Medicine

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes t…

  2. F2

    Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Original filing · 0000200406-26-000175
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

JNJ